Commercializing Healthcare Solutions in the U.S., July 26, 2018
VentureLAB brings you a collaborative workshop offering real-world, practical tools, frameworks and tips for commercializing digital healthcare solutions in the U.S. market.
Accel-Rx Portfolio Companies Secure $40 Million Follow-On Funding
KisoJi, SoundBite and Zucara, three of Accel-Rx’s portfolio companies, together raised a total of $40 million CDN in follow-on funding to advance the development and commercialization of their technologies.
New Guide Addresses Procurement Myths to Promote Innovation Adoption in Ontario
The Council of Academic Hospitals of Ontario (CAHO) has published a quick reference guide to help tackle procurement myths to pull innovation into the health system faster.
Investor Spotlights: Amgen and AmorChem - JLABS Toronto
JLABS Meet with.. Series helps build partnerships with Amgen and AmorChem. Amgen is seeking for opportunities in relation to their capabilities in oncology, bone health, nephrology, metabolic disorders, neuroscience, inflammation, cardiovascular, discovery research and technology. AmorChem involves financing research-stage projects for them to reach pre-clinical proof-of-concept in a semi-virtual mode.
Antibe Therapeutics Releases Secondary Endpoint Data for Lead Drug
Toronto’s Antibe Therapeutics released positive secondary endpoint data, conducted in their 244 patients, from the recent Phase 2B Gastrointestinal safety study for its lead drug, ATB-346. These results are consistent with the primary endpoint data, previously released on March 20, 2018.
Government of Canada Announces Stream 4 of the Strategic Innovation Fund
The Government of Canada has announced Stream 4 of the Strategic Innovation Fund and that Statements of Interest will be accepted until August 31, 2018.
Ontario Trade Mission to AdvaMed 2018: The MedTech Conference, September 24-26, 2018
Ontario's Ministry of International Trade is organizing a Trade Mission to AdvaMed 2018: The MedTech Conference, September 24-26, 2018, Pennsylvania Convention Center. This Trade Mission will be able to accommodate a maximum of eight Ontario companies.
Ontario 2018 Rehabilitation & Assistive Device Mission to China
Ontario companies with capabilities in rehabilitation or assistive technology and device that can help China better take care of its disabled and aging population are warmly invited to B2B meetings, site visits and briefing, seminars/forum, and exhibitions of the Canada Pavilion at the 2018 China International Care & Rehabilitation Expo (CRE) in Beijing.
Perimeter Medical Appoints New CEO
Perimeter is pleased to announce the appointment of Charles S. Carignan as the New CEO, who has an extensive experience in developing and commercializing innovative OCT based tissue imaging solutions.
Seeking Digital Health Companies for Springboard Health Hub
Springboard is recruiting women-led digital health companies to join their 2018 Health Innovation Hub cohort to help those seeking growth funding accelerate through an inflection point of growth.
CellAegis Completes Patient Enrollment in Trial
CellAegis completed its patient enrollment in a large-scale, UK investigator-sponsored trial to further assess the efficacy of remote ischemic conditioning in reducing clinical events in patients presenting with STEMI in patients receiving treatment in hospital catheterization labs or emergency rooms.
Ontario Announces Trade Mission to RESI Boston, September 2018
Ontario's Ministry of International Trade, is organizing a Trade Mission to the RESI Conference, September 6, 2018, Boston Marriott Copley Place Hotel. This Trade Mission will be able to accommodate a maximum of ten Ontario companies.
"Dream a Bigger Dream" Presentation by Scott Phillips, CEO, Starfish Medical
If you missed the Medical Device Playbook hosted by StarFish Medical and OBIO, you can still watch Starfish CEO Scott Phillips' presentation titled "Dream a Bigger Dream".
Radialis Medical Wins Pitch Competition
Radialis Medical won the Thunder Bay PITCH competition co-hosted by Northern Ontario Angels (NOA) and the Northern Ontario Innovation Centre (NOIC). Competitors' pitches were made to a panel of angel investors who voted on the best pitch.
Proteocyte AI Announces Partnership With Proscia Digital
Proteocyte AI announced they have signed a partnership agreement to integrate Proscia’s technology with Straticyte™, a specific test for predicting the risk of progression to oral cancer.
OBIO CAAP Company Swift Medical Raises $11.6 Million in Oversubscribed Series A
Swift Medical, the world leader in enterprise-grade digital wound care management, has secured $11.6 million in funding
Applications Open for OBI ONtrepreneurs Program
Applications for the 2018 ONtrepreneurs Competition are now open. The Ontario Neurotech Entrepreneurs (ONtrepreneurs) Program catalyzes early stage entrepreneurs to commercialize brain-related technologies by accessing funding and support to launch or grow their neurotechnology ventures.
OBIO CAAP Company: Polumiros Wins 2018 FACIT Falcons' Fortunes competition
A panel of investor-judges has selected Ontario-based oncology researcher Soror Sharifpoor of Polumiros Inc. as the winner of the 2018 FACIT Falcons' Fortunes competition. The $50,000 award is intended to support further development of their innovative cancer research.
OBIO Pre-CAAP Company Adrenalease Launches KickStarter Campaign
Adrenalease announced the launch of a Kickstarter campaign to back their wearable posture apparel line. Once the campaign ends, the clothing is set to produce and ship to all backers by August 2018.
VBI Vaccines Announces Completion of Enrollment in PROTECT Phase 3 Clinical Study
VBI Vaccines announced the completion of enrollment with the last patient receiving the first dose in the ongoing PROTECT Phase 3 study of Sci-B-Vac®, the company’s third-generation hepatitis B vaccine.